<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-106785</identifier>
<setSpec>0300-8932</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Flecainide, a therapeutic option in a patient with long QT syndrome type 3 caused by the heterozygous V411M mutation in the SCN5A gene</dc:title>
<dc:description xml:lang="en">No disponible</dc:description>
<dc:creator>Izquierdo, Isabel</dc:creator>
<dc:creator>Medina, Pilar</dc:creator>
<dc:creator>Zorio, Esther</dc:creator>
<dc:creator>Carrasco, José Ignacio</dc:creator>
<dc:creator>Arnau, Miguel Ángel</dc:creator>
<dc:creator>Salvador, Antonio</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">No disponible</dc:description>
<dc:source>Rev Esp Cardiol;65(11): 1058-1059, nov. 2012. ilus</dc:source>
<dc:identifier>ibc-106785</dc:identifier>
<dc:title xml:lang="es">Flecainida, una opción terapéutica en una paciente con síndrome de QT largo tipo 3 por la mutación V411M en heterocigosis en el gen SCN5A</dc:title>
<dc:subject>^d7399</dc:subject>
<dc:subject>^d4634^s22045</dc:subject>
<dc:subject>^d1151^s22057</dc:subject>
<dc:subject>^d4634^s22066</dc:subject>
<dc:subject>^d1151^s22012</dc:subject>
<dc:subject>^d52608^s22067</dc:subject>
<dc:subject>^d11865^s22073</dc:subject>
<dc:subject>^d29638</dc:subject>
<dc:subject>^d1151^s22016</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d4634^s22039</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d30449^s22079</dc:subject>
<dc:subject>^d30449^s22044</dc:subject>
<dc:subject>^d30449^s22000</dc:subject>
<dc:subject>^d30449^s22073</dc:subject>
<dc:type>article</dc:type>
<dc:date>201211</dc:date>
</metadata>
</record>
</ibecs-document>
